BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 22, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2016

View Archived Issues

Genentech initiates phase I trial of GDC-0134 in patients with ALS

Read More

Worldwide collaborations to control recent Zika virus outbreaks / News in Context

Read More

Researchers identify germline variants associated with melanoma prognosis

Read More

FDA approves Athenex's IND application for oradoxel

Read More

FDA accepts BLA submission for brodalumab in moderate to severe plaque psoriasis

Read More

Ixchelsis reports positive phase IIa results for IX-01 as treatment of premature ejaculation

Read More

Domainex and Cresset Discovery Services form alliance

Read More

Alkermes begins phase I clinical testing of ALKS-7119

Read More

FDA accepts for review cardiovascular outcomes data for Jardiance

Read More

Phase IIa study of GLPG-1205 in ulcerative colitis does not meet efficacy endpoints

Read More

Steba completes phase III trial of Tookad, submits MAA

Read More

Biomarkers linked to metastasis of endometrial and lung tumors

Read More

OncoMed unblinds phase II trial of tarextumab following DSMB analysis

Read More

Shire resubmits NDA for lifitegrast for dry eye disease

Read More

Results from part A of MoveDMD trial of CAT-1004 support progression to part B

Read More

WuXi Healthcare Ventures invests in Twist Bioscience and Syros Pharmaceuticals

Read More

Pharmaceutical industry calls for government collaboration to fight antibiotic resistance

Read More

Polish institutions report 5-HT/dopamine receptor modulators

Read More

Moberg Pharma issues a 5-year senior unsecured bond loan

Read More

Sunshine Lake Pharma discloses JAK3 inhibitors

Read More

Novartis reports soluble guanylate cyclase activators

Read More

Galapagos and Gilead Sciences file transparency notification

Read More

New animal model designed to reproduce ischemia in head and neck surgery

Read More

3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum

Read More

Tissue-engineered cartilage shows promise for laryngotracheal reconstruction

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing